Aadi Bioscience, Inc. (AADI) Q2 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Addi Bioscience Incorporated second quarter 2023 earnings call. At this time all participants are in a listen only mode. After the speaker's presentation there will be a question and answer session. To ask a question during the session you will need to press star 1 1 on your telephone. You will then hear an automated message advising that your hand is raised. To withdraw your question please press star 1 1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to Marci Graham, Senior Vice President of Investor Relations and Corporate Communications at Addi Biosciences. Ms. Graham. Thank you. Good morning and welcome to the Addi Bioscience conference call to provide an operational update and review results of the second quarter 2023. Joining me on the call today is Scott Giacobbello, our CFO and interim president and CEO, who will provide an overview of financial and operational activity during the period, including an update on our continued commercial progress. And he will be followed by our chief medical officer, Dr. Loretta Etri, who will provide an update on our Precision 1 study and clinical development plans for 2023. We will open the line for questions at the end of the call, following closing comments. A quick reminder that statements made on the call today will include forward-looking statements. Actual events or results could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties, and other factors, including those set forth in the risk factor section of our annual and quarterly filing with the Securities and Exchange Commission, which can be found at www.sec.gov. or on our ...